Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program


Autoria(s): Kollár, Attila; Maruzzo, Marco; Messiou, Christina; Cartwright, Elisabeth; Miah, Aisha; Martin-Liberal, Juan; Thway, Khin; McGrath, Ellen; Dunlop, Alison; Khabra, Komel; Seddon, Beatrice; Dileo, Palma; Linch, Mark; Judson, Ian Robert; Benson, Charlotte
Data(s)

2014

Formato

application/pdf

Identificador

http://boris.unibe.ch/62858/1/2045-3329-4-17.pdf

Kollár, Attila; Maruzzo, Marco; Messiou, Christina; Cartwright, Elisabeth; Miah, Aisha; Martin-Liberal, Juan; Thway, Khin; McGrath, Ellen; Dunlop, Alison; Khabra, Komel; Seddon, Beatrice; Dileo, Palma; Linch, Mark; Judson, Ian Robert; Benson, Charlotte (2014). Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program. Clinical Sarcoma Research, 4(1), p. 17. Biomed Central 10.1186/2045-3329-4-17 <http://dx.doi.org/10.1186/2045-3329-4-17>

doi:10.7892/boris.62858

info:doi:10.1186/2045-3329-4-17

urn:issn:2045-3329

Idioma(s)

eng

Publicador

Biomed Central

Relação

http://boris.unibe.ch/62858/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Kollár, Attila; Maruzzo, Marco; Messiou, Christina; Cartwright, Elisabeth; Miah, Aisha; Martin-Liberal, Juan; Thway, Khin; McGrath, Ellen; Dunlop, Alison; Khabra, Komel; Seddon, Beatrice; Dileo, Palma; Linch, Mark; Judson, Ian Robert; Benson, Charlotte (2014). Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program. Clinical Sarcoma Research, 4(1), p. 17. Biomed Central 10.1186/2045-3329-4-17 <http://dx.doi.org/10.1186/2045-3329-4-17>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed